Table 4.
KEGG enrichment analysis of all differentially expressed transcripts in ML vs. PL.
| Pathway Name | p-Value | Genes |
|---|---|---|
| Cell adhesion molecules (CAMs) | 0.01 | ITGAV, JAM2 |
| Glycosaminoglycan degradation | 0.02 | ARSB |
| Dorso-ventral axis formation | 0.02 | SPIRE1 |
| Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 0.06 | ITGAV |
| Hypertrophic cardiomyopathy (HCM) | 0.06 | ITGAV |
| Dilated cardiomyopathy | 0.07 | ITGAV |
| ECM-receptor interaction | 0.07 | ITGAV |
| Small cell lung cancer | 0.08 | ITGAV |
| Protein digestion and absorption | 0.09 | COL14A1 |
| Thyroid hormone signaling pathway | 0.10 | ITGAV |
| Lysosome | 0.10 | ARSB |
| Leukocyte transendothelial migration | 0.10 | JAM2 |
| Tight junction | 0.11 | JAM2 |
| Phagosome | 0.13 | ITGAV |
| Focal adhesion | 0.16 | ITGAV |
| Proteoglycans in cancer | 0.17 | ITGAV |
| Regulation of actin cytoskeleton | 0.17 | ITGAV |
| Pathways in cancer | 0.25 | ITGAV |
| PI3K-Akt signaling pathway | 0.26 | ITGAV |
| Metabolic pathways | 0.66 | ARSB |